Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update is a research paper published in Clinical Pharmacology & Therapeutics (2022). On theSindex it has a DataRank of 8.6. It has been cited 473 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.924
From this paper's citation signal
Citation Network Contribution
7.7
From 200 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
National Institutes of Health
Grant: R24GM115264
National Institutes of Health
Grant: U24HG010135
NIGMS NIH HHS
Grant: R24 GM123930
NHGRI NIH HHS
Grant: U24 HG010615
NCATS NIH HHS
Grant: UL1 TR003098
NHLBI NIH HHS
Grant: K08 HL146990
NHLBI NIH HHS
Grant: K24 HL133373
NHLBI NIH HHS
Grant: R01 HL149752
NIGMS NIH HHS
Grant: R35 GM131770
NHLBI NIH HHS
Grant: R01 HL092173
National Institutes of Health
Grant: 5U24HG010135-03
Clinical Pharmacogenetics Implementation Consortium (CPIC)
National Institutes of Health
Grant: 5R01HL092173-14
Predictors of hemorrhage among patients on direct acting oral anticoagulants
National Institutes of Health
Grant: 5U24HG010615-02
PharmGKB: pharmacogenomics discovery and implementation
National Institutes of Health
Grant: 1R24GM115264-01
Clinical Pharmacogenetics Implementation Consortium (CPIC)
National Institutes of Health
Grant: 5K08HL146990-03
Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy
National Institutes of Health
Grant: 5UL1TR003098-02
Johns Hopkins Institute for Clinical and Translational Research
National Institutes of Health
Grant: 5R35GM131770-03
Pharmacogenetics to improve drug therapy
National Institutes of Health
Grant: 5R24GM123930-03
PHARMacogene VARiation Consortium
National Institutes of Health
Grant: 5K24HL133373-03
Patient Oriented Research in Personalized Antithrombotic Therapy
National Institutes of Health
Grant: 1R01HL149752-01A1
Precision antiplatelet therapy after percutaneous coronary intervention
FWCI
61.06
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals